Afraid of taking menopause hormone therapy? Been told it's dangerous, not for you or that it's "too late to start"?

For decades, menopause hormone therapy (MHT) has been clouded by outdated studies, conflicting headlines, and fear-based medicine. Join Dr. Genevieve Neal-Perry – leading menopause researcher and Chair of Obstetrics & Gynecology at UNC School of Medicine – for a one-hour conversation on what hormone therapy actually does, who's a candidate (and who isn't), and how to advocate for the care you deserve.

This talk is for anyone considering MHT or simply trying to make sense of the conflicting information you've heard from friends, doctors, and the media. Join us for a fact based discussion on:

• How the history of MHT research has shaped access to and myths around MHT
• The differences between local, systemic, and “birth control” MHT options
• The truth about MHT and breast cancer risk, how today's science differs from the 2002 headlines, and what to think about the removal of the black box warning
• How to know if you're a candidate, what type to consider, and when to start
• What to ask your doctor – and what to do if they're not up to speed on the latest evidence

Leave feeling empowered with newfound knowledge to advocate for the hormone therapy care you deserve.

Note: If you’re unable to attend live, we will share a video replay of the talk with anyone who has RSVP’d.

‍

About the Speaker

Genevieve Neal-Perry, MD, PhD
Dr. Genevieve Neal-Perry is the Robert A. Ross Distinguished Professor and Chair of Obstetrics and Gynecology at the University of North Carolina at Chapel Hill. She earned her BA in Biology from Dartmouth College and her MD and PhD from Rutgers University and Robert Wood Johnson Medical School, followed by fellowship training in Reproductive Endocrinology and Infertility. As Chair, Dr. Neal-Perry leads a robust academic department with a strong emphasis on research excellence and career development. The department receives more than $25 million annually in NIH and non-NIH research funding, serves as the institutional home for the Women’s Reproductive Health Research (WRHR) and Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) programs, and sustains a vibrant culture of discovery, with approximately one-third of faculty actively engaged in research. Dr. Neal-Perry is a nationally recognized expert in menopause, neuroendocrinology, reproductive aging, and fertility. Her research has advanced understanding of estrogen signaling, aging, and brain–reproductive interactions, helping to inform both non-hormonal therapies and national hormone therapy guidelines. She has served on the NIH Advisory Council and held leadership roles in the Endocrine Society, the Society for Reproductive Investigation, and the American Society for Reproductive Medicine. Her work includes contributions to landmark studies such as SWAN and KEEPS, as well as research that supported the development of the two recently FDA-approved non-hormonal therapies for menopausal vasomotor symptoms, fezolinetant (Veozah) and elinzanetant (Lynkuet).